Overall, CEACAM1 is downregulated in colorectal cancer, upregulated in gastric cancer, and directly correlated with decreased overall survival in HCC and gastric cancer [32, 82–84, 97, 98]. This evidence concerns the gene CEACAM1 and colorectal cancer.